Literature DB >> 25109927

Polypoidal choroidal vasculopathy in adult chinese: the Beijing Eye Study.

Yang Li1, Qi Sheng You2, Wen Bin Wei3, Jie Xu1, Chang Xi Chen2, Ya Xing Wang2, Liang Xu2, Jost B Jonas4.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25109927     DOI： 10.1016/j.ophtha.2014.06.016

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  14 in total

1.  A comparison of risk factors for age-related macular degeneration and polypoidal choroidal vasculopathy in Chinese patients.

Authors:  Xiao-Li Chen; Qin-Rui Hu; Yu-Jing Bai; Yu Deng; Hai-Wei Wang; Shan Liu; Yin-Lin Wang; Yan-Kun Yue
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-01       Impact factor: 3.117

2.  Polypoidal Choroidal Vasculopathy.

Authors:  Raquel Goldhardt; Bradley Simon Rosen
Journal:  Curr Ophthalmol Rep       Date:  2019-02-02

Review 3.  Polypoidal Choroidal Vasculopathy in Asians.

Authors:  Chee Wai Wong; Tien Y Wong; Chui Ming Gemmy Cheung
Journal:  J Clin Med       Date:  2015-04-24       Impact factor: 4.241

Review 4.  Polypoidal choroidal vasculopathy: An update on current management and review of literature.

Authors:  Amit Harishchandra Palkar; Vikas Khetan
Journal:  Taiwan J Ophthalmol       Date:  2019 Apr-Jun

5.  Prevalence of polypoidal choroidal vasculopathy in Indian population: Risk factors, clinical and imaging characteristics.

Authors:  Meenakshi Kumar; Sangeetha E Moptom; Parveen Sen; Vikas Khetan; Muna Bhende; Sobha Sivaprasad; Rajiv Raman
Journal:  PLoS One       Date:  2020-04-28       Impact factor: 3.240

6.  Polypoidal Choroidal Vasculopathy.

Authors:  Joon-Bom Kim; Rajinder S Nirwan; Ajay E Kuriyan
Journal:  Curr Ophthalmol Rep       Date:  2017-04-21

7.  Clinical characteristics of super stable polypoidal choroidal vasculopathy after initial remission with anti-VEGF monotherapy.

Authors:  Seonghee Choi; Hae Min Kang; Hyoung Jun Koh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-11-27       Impact factor: 3.117

Review 8.  Pachychoroid: current concepts on clinical features and pathogenesis.

Authors:  Veronica Castro-Navarro; Francine Behar-Cohen; Woohyok Chang; Antonia M Joussen; Timothy Y Y Lai; Rafael Navarro; Ian Pearce; Yasuo Yanagi; Annabelle A Okada
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-10-15       Impact factor: 3.117

9.  Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy.

Authors:  Prashant Jain; Giridhar Anantharaman; Mahesh Gopalakrishnan; Anubhav Goyal
Journal:  Indian J Ophthalmol       Date:  2018-08       Impact factor: 1.848

10.  Five-year real-world outcomes of anti-vascular endothelial growth factor monotherapy versus combination therapy for polypoidal choroidal vasculopathy in a Chinese population: a retrospective study.

Authors:  Jingyuan Yang; Mingzhen Yuan; Erqian Wang; Song Xia; Youxin Chen
Journal:  BMC Ophthalmol       Date:  2019-11-21       Impact factor: 2.209
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.